(IUS) Invesco RAFI Strategic US - Ratings and Ratios
Large-Cap, Quality, Equity, Replication, Index
Dividends
| Dividend Yield | 1.44% |
| Yield on Cost 5y | 2.92% |
| Yield CAGR 5y | 8.69% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 11.2% |
| Value at Risk 5%th | 19.0% |
| Relative Tail Risk | 3.39% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.57 |
| Alpha | 0.84 |
| CAGR/Max DD | 1.18 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.355 |
| Beta | 0.795 |
| Beta Downside | 0.837 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.61% |
| Mean DD | 2.01% |
| Median DD | 1.28% |
Description: IUS Invesco RAFI Strategic US October 23, 2025
The Invesco RAFI Strategic US ETF (NASDAQ:IUS) seeks to track an index of large-cap U.S. equities that exhibit higher quality and larger business scales. The adviser uses a full-replication approach, investing in at least 80 % of the fund’s assets across virtually all securities in the index, weighted in line with the index composition.
Key metrics as of the latest filing: the fund carries an expense ratio of 0.13 % and manages roughly $5 billion in assets, with a low turnover rate of about 5 % over the past year, indicating minimal trading drag. Its top holdings typically include large-value names such as Berkshire Hathaway, JPMorgan Chase, and Johnson & Johnson, giving the portfolio a sector tilt toward financials, consumer staples, and health care. Performance is closely tied to macro drivers like the Federal Reserve’s interest-rate policy and corporate earnings growth, which historically affect large-value stocks more than growth-oriented peers.
If you want a deeper, data-driven look at IUS’s valuation profile and risk characteristics, ValueRay’s analysis can provide useful additional context.
What is the price of IUS shares?
Over the past week, the price has changed by +0.22%, over one month by +1.55%, over three months by +5.43% and over the past year by +13.55%.
Is IUS a buy, sell or hold?
What are the forecasts/targets for the IUS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 67.5 | 17.4% |
IUS Fundamental Data Overview December 09, 2025
Beta = 0.92
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 698.9m USD (698.9m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 698.9m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 698.9m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.95% (E(698.9m)/V(698.9m) * Re(8.95%) + (debt-free company))
Discount Rate = 8.95% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IUS ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle